The Histochemical Localization of Alkaline Phosphatase in Tooth Supporting Tissues of Rat
Syoichi SUGA+2 more
openalex +2 more sources
Bone fracture healing is a complex, timely orchestrated scenario involving multiple cell types and a plethora of cytokines and regulatory factors. To gain further insight, an in vitro model to a) study macrophage polarization under mechanical load in a fibrin hydrogel and b) subsequently assess the effect of conditioned media derived from macrophages ...
Anne Géraldine Guex+4 more
wiley +1 more source
Caveolin-1 Regulates Parathyroid Hormone (PTH)-Related Protein (PTHrP) Actions on PTH Receptor Type 1 in Bone Cells. [PDF]
Heredero-Jiménez S+7 more
europepmc +1 more source
The Phosphatase Activity of Chocolate Milk
F.V. Kosikowski, A.G. Wolin, W.F. Witter
openalex +1 more source
COMPARATIVE VALUE OF BROMSULPHALEIN, SERUM PHOSPHATASE, PROTHROMBIN TIME, AND INTRAVENOUS GALACTOSE TOLERANCE TESTS IN DETECTING HEPATIC DAMAGE PRODUCED BY CARBON TETRACHLORIDE [PDF]
Victor A. Drill, A. C. Ivy
openalex +1 more source
Si Inhibited Osteoclastogenesis: The Role of Fe and the Fenton Reaction
Silicate (Si) inhibition of osteoclastogenesis, is mediated by Fe. Si chemical interactions with Fe inhibit the Fenton reaction and intercellular ROS availability. This reduction in ROS availability inhibits osteoclastogenesis. The addition of Fe, in Si‐inhibited osteoclast cultures, restores the Fenton reaction, and osteoclastogenesis.
Yutong Li+7 more
wiley +1 more source
Mineral Bone Disease Prevalence and Biochemical Profile in Chronic Kidney Disease Patients Undergoing Hemodialysis. [PDF]
George J, Bhat RS.
europepmc +1 more source
SODIUM PHENOLPHTHALEIN PHOSPHATE AS A SUBSTRATE FOR PHOSPHATASE TESTS
Charles Huggins, Paul Talalay
openalex +1 more source
Lymphoid and CXCR4 Cell Targeted Lipid Nanoparticles Facilitate HIV‐1 Proviral DNA Excision
Advancements in ART improve HIV‐1 patient outcomes but are unable to eliminate latent viral DNA. To address this, CXCR4‐targeted lipid nanoparticles (T‐LNPs) for delivering CRISPR‐Cas9 to excise HIV‐1 DNA in infected cells are developed. These T‐LNPs achieve ≈60% HIV‐1 DNA excision efficacy in blood and splenic tissue, demonstrating promise for ...
Sudipta Panja+6 more
wiley +1 more source